Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Andreas Culora, analyst in the home affairs and social policy group at RAND Europe, highlights the heightened exposure to COVID-19 for children living in poor quality housing.
Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.
Stephen Boyle, TeleTracking UK’s Product Specialist, recently returned to front line Critical Care nursing at East Cheshire NHS Trust in response to COVID-19. Here, he argues that most changes made within the NHS have been driven by necessity and not intentional innovation.
Martin McFadyen, Head of Public Sector, Virgin Media Business, explains why investing in technology will help us move from reaction to recovery amid the COVID-19 pandemic.
Thomas Bradley, content writer at Lookers BMW, explores how automation could shape the future of business and how it may, in fact, play a part in helping the environment too.
Justin Hall, GM and VP EMEA, iRhythm Technologies, explores the impact that COVID-19 has had on the rapid scaling of new technology-enabled healthcare services.
